Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment
Neural Plasticity · 21.10.2021 · 2021 · 1-10
DOI: 10.1155/2021/4762027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neural Plasticity, erschienen am 21.10.2021. Verfasst von Zijian Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Judgment. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Family Planning Commission of Jiangxi Province, Natural Science Foundation of Jiangxi Province, Key Project of Jiangxi Science Foundation.
Abstract (Originalsprache)
Background
The relationship between the levodopa challenge test (LDCT) and postoperative subthalamic nucleus-deep brain stimulation (STN-DBS) benefits is controversial in patients with Parkinson’s disease (PD). We aim to evaluate the value of total levodopa response (TLR) and symptom levodopa response (SLR) in predicting postoperative improvement in different PD motor subtypes.
Methods
Studies were split into a training set (147 patients) and a validation set (304 patients). We retrospectively collected data from 147 patients who received the Unified Parkinson’s Disease Rating Scale- (UPDRS-) III and the Parkinson’s Disease Questionnaire- (PDQ-) 39 evaluation. Patients were classified into tremor-dominant (TD), akinetic-rigid-dominant (AR), and mixed (MX) groups. Clinically important difference (CID) was employed to dichotomize DBS effects. For patients in each subtype group from the training set, we used the correlation and receiver operator characteristic (ROC) curve analyses to explore the strength of their relations. Areas under the curve (AUCs) were calculated and compared through the DeLong test. Results developed from the training set were applied into the validation set to predict postoperative improvement in different PD motor subtypes.
Results
In the validation cohort, TLR significantly correlated with postoperative motor ( p < 0.001 ) and quality of life (QOL) ( p < 0.001 ) improvement in the MX group. The AUC between TLR and UPDRS-III (TU) is 0.800. The AUC between TLR and PDQ-39 (TP) is 0.770. An associated criterion in both TU and TP is around 50%. In the AR group, strong correlation was only found in SLR and PDQ-39 (SP) ( p < 0.001 ). And the AUC of SP is significantly larger than that in TLR and PDQ-39 (TP) ( p = 0.034 ). An associated criterion in SP is around 37%. No significant correlation was found in the TD group.
Conclusions
We provide a more accurate judgment for LDCT. TLR strongly correlated with postoperative UPDRS-III and PDQ-39 improvement in MX patients. A TLR > 50 % may indicate a higher possibility of clinically meaningful benefits from STN-DBS comparing to medication only. SLR can well predict QOL improvement in AR patients. Similarly, a SLR > 37 % may indicate a higher possibility of clinically significant benefits from STN-DBS. LDCT provides limited information for TD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- The First Clinical Medical College of Nanchang University, Nanchang, Jiangxi, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
- Department of Neurosurgery, Changhai Hospital of the Second Military Medical University of Chinese PLA, Shanghai, China.
Förderung
- Health and Family Planning Commission of Jiangxi Province
- Natural Science Foundation of Jiangxi Province
- Key Project of Jiangxi Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zheng, Z., Yin, Z., Zhang, B., Fan, H., Liu, D., Zhou, Y., Duan, J., Zhou, D., Wu, X., & Lu, G. (2021). Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment. Neural Plasticity, 2021, 1-10. https://doi.org/10.1155/2021/4762027
Vancouver
Zheng Z, Yin Z, Zhang B, Fan H, Liu D, Zhou Y, et al. Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment. Neural Plasticity. 2021;2021:1-10. doi:10.1155/2021/4762027
BibTeX
@article{Zheng2021,
author = {Zheng, Zijian and Yin, Zixiao and Zhang, Bohan and Fan, Houyou and Liu, Dan and Zhou, Yuancheng and Duan, Jian and Zhou, Dongwei and Wu, Xi and Lu, Guohui},
title = {Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson’s Disease Motor Subtypes: A More Accurate Judgment},
journal = {Neural Plasticity},
year = {2021},
volume = {2021},
pages = {1--10},
doi = {10.1155/2021/4762027}
}
EUVIMED